CD8A and head and neck squamous cell carcinoma: For example, a meta-analysis by Yang et al. [33] found no significant differences in OS and progression-free survival (PFS) between PD-L1 positive and negative OPSCC; however, low CD8+ TIL HNSCC and worse OS was observed in the PD-L1 positive subgroup.